• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Pre-Paid Legal Services

Pre-Paid Legal Services

  1. Sage Therapeutics Reports Top-Line Results from Phase 3 STATUS Trial of Brexanolone in Super-Refractory Status Epilepticus

    Sage Therapeutics Reports Top-Line Results from Phase 3 STATUS Trial of Brexanolone in Super-Refractory Status Epilepticus

12

©2017 Morningstar Advisor. All right reserved.